# Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection

> **NCT05410223** · NA · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 100 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline, Bismuth
- **DRUG:** IIaprazole, Amoxicillin/Clarithromycin/Furazolidone, Doxycycline, Bismuth
- **DRUG:** Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline
- **DRUG:** IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline, Bismuth

## Key facts

- **NCT ID:** NCT05410223
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-06
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05410223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05410223, "Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05410223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*